- Home
- NRIM vs CATX Comparison
NRIM vs CATX Comparison
Compare NRIM & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRIM | CATX |
|---|---|---|
| Founded | 1990 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 544.8M | 497.9M |
| IPO Year | 2002 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NRIM | CATX |
|---|---|---|
| Price | $26.57 | $2.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.11 |
| AVG Volume (30 Days) | 125.1K | ★ 1.7M |
| Earning Date | 04-22-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.62% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $255,581,000.00 | N/A |
| Revenue This Year | $4.98 | N/A |
| Revenue Next Year | $7.40 | N/A |
| P/E Ratio | $42.77 | ★ N/A |
| Revenue Growth | ★ 30.43 | N/A |
| 52 Week Low | $19.60 | $1.96 |
| 52 Week High | $99.18 | $6.16 |
Technical Indicators
Market Signals| Indicator | NRIM | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 67.03 | 33.04 |
| Support Level | $26.26 | $2.94 |
| Resistance Level | $28.10 | $2.96 |
| Average True Range (ATR) | 0.81 | 0.19 |
| MACD | 0.11 | 0.01 |
| Stochastic Oscillator | 90.18 | 12.82 |
Price Performance
Historical ComparisonAbout NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company operating through three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. The Community Banking segment, which generates the majority of revenue, provides loan and deposit products to business and consumer customers in its market areas. The Home Mortgage Lending segment focuses on the origination and sale of mortgage loans for one-to-four family residential properties, mortgage loan servicing for certain loans sold, and investment in selected residential mortgage loans. The Specialty Finance segment provides factoring, asset-based lending, and alternative working capital solutions to small and medium-sized enterprises and includes SCF and Northrim Funding Services.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.